Showing results (491-500 of 2,849) with videos related to
Sort By:
Pageof 285
F1000Research|March 10, 2020
Microbial transformation of widely used pharmaceutical and personal care product compoundsAbigail W Porter, Sarah J Wolfson, Max Häggblom, et al.Spine|November 1, 1987
The vertebral canal: II. Health and academic status, a clinical studyR W Porter, J N Drinkall, D E Porter, et al.Cancer Research|March 1, 1986
Comparison of the biological effects of four irreversible inhibitors of ornithine decarboxylase in two murine lymphocytic leukemia cell linesP J Pera, D L Kramer, J R Sufrin, et al.Biochemical Pharmacology|October 26, 1995
Cationic porphyrin derivatives as inhibitors of polyamine catabolismP R Libby, B R Munson, R J Fiel, et al.Journal of Neurosurgery|October 10, 1997
De novo formation of a central nervous system cavernous malformation: implications for predicting risk of hemorrhage. Case report and review of the literatureP W Detwiler, R W Porter, J M Zabramski, et al.Chemical Research in Toxicology|December 1, 1996
Mechanistic studies of the inhibition of MutT dGTPase by the carcinogenic metal Ni(II)D W Porter, V C Nelson, M J Fivash, et al.The Journal of Biological Chemistry|September 5, 1993
Polyamine and polyamine analog regulation of spermidine/spermine N1-acetyltransferase in MALME-3M human melanoma cellsM Fogel-Petrovic, N W Shappell, R J Bergeron, et al.Nanotoxicology|December 28, 2016
Thrombospondin-1 mediates multi-walled carbon nanotube induced impairment of arteriolar dilationW Kyle Mandler, Timothy R Nurkiewicz, Dale W Porter, et al.Anticancer Research|July 1, 1992
Differential effects of the spermine analog, N1, N12-bis(ethyl)-spermine, on polyamine metabolism and cell growth in human melanoma cell lines and melanocytesN W Shappell, J T Miller, R J Bergeron, et al.Molecular Pharmacology|October 24, 2003
Small interfering RNA suppression of polyamine analog-induced spermidine/spermine n1-acetyltransferaseYing Chen, Debora L Kramer, Jason Jell, et al.Pageof 285